- Category :
Pharmaceuticals and Biochemicals
- CAS NO : 668270-12-0
- EC NO :
- Molecular Formula : C25H28N8O2
- Main Specifications : 99%
- Synonyms : 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;
Package: As customer request
Uses : A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
Molecular Structure:
Product description:
Product Name: Linagliptin
Synonyms: Tradjenta;Linagliptin-D4;Linagliptin (BI-1356);Linaglitine;(R)-8-(3-aMinopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;Linagliptin API
CAS: 668270-12-0
MF: C25H28N8O2
MW: 472.54
EINECS: 1308068-626-2
Melting point 202 ºC
density 1.39
Uses:
1.A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
2.dipeptidypeptidase inhibitor, antidiabetic
3.highly potent CD26 inhibitor
4.Labeled Linagliptin, intended for use as an internal standard for the quantification of Linagliptin by GC- or LC-mass spectrometry.
Contact Supplier
Search Product